Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Michael E. Fassbender"'
Autor:
Artem V. Matyskin, Athanasios Stamatopoulos, Ellen M. O’Brien, Brad J. DiGiovine, Veronika Mocko, Michael E. Fassbender, C. Etienne Vermeulen, Paul E. Koehler
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-16 (2023)
Abstract A process for the production of tens to hundreds of GBq amounts of zirconium-88 (88Zr) using proton beams on yttrium was developed. For this purpose, yttrium metal targets (≈20 g) were irradiated in a ~16 to 34 MeV proton beam at a beam cu
Externí odkaz:
https://doaj.org/article/e313a4f13d9d4ead9949bbf96359d198
Autor:
Kevin T. Bennett, Sharon E. Bone, Andrew C. Akin, Eva R. Birnbaum, Anastasia V. Blake, Mark Brugh, Scott R. Daly, Jonathan W. Engle, Michael E. Fassbender, Maryline G. Ferrier, Stosh A. Kozimor, Laura M. Lilley, Christopher A. Martinez, Veronika Mocko, Francois M. Nortier, Benjamin W. Stein, Sara L. Thiemann, Christiaan Vermeulen
Publikováno v:
ACS Central Science, Vol 5, Iss 3, Pp 494-505 (2019)
Externí odkaz:
https://doaj.org/article/116aeabb09ca4141a5f9a9981eb10e94
Autor:
Tara Mastren, Valery Radchenko, Allison Owens, Roy Copping, Rose Boll, Justin R. Griswold, Saed Mirzadeh, Lance E. Wyant, Mark Brugh, Jonathan W. Engle, Francois M. Nortier, Eva R. Birnbaum, Kevin D. John, Michael E. Fassbender
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-7 (2017)
Abstract A new method has been developed for the isolation of 223,224,225Ra, in high yield and purity, from a proton irradiated 232Th matrix. Herein we report an all-aqueous process using multiple solid-supported adsorption steps including a citrate
Externí odkaz:
https://doaj.org/article/c4ce5e09c2234701ae14e728aa214ee6
Autor:
D. Scott Wilbur, Andrew C. Akin, Eva R. Birnbaum, Mark Brugh, Michael E. Fassbender, Kevin D. John, Tara Mastren, Francois M. Nortier, Roy Copping
Publikováno v:
Nuclear Medicine and Biology. :69-73
Purpose Thorium-226 (half-life 30.6 m) is a radionuclide of interest for use in targeted alpha therapy applications. Due to its short half-life, 226Th must be provided through a radionuclide generator system from its parent 230U (20.8 d). Furthermore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fcf2666956fe80f96a5cce9c10c42cb
https://doi.org/10.1016/j.nucmedbio.2020.09.006
https://doi.org/10.1016/j.nucmedbio.2020.09.006
Autor:
Meiring F. Nortier, Tara Mastren, Eva R. Birnbaum, C. Vermeulen, Mark Brugh, Michael E. Fassbender
Publikováno v:
Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms. 443:1-4
The degradation of proton beam energy within a target stack was monitored via product nuclide ratios at the Los Alamos Isotope Production Facility (LANL-IPF). Nuclear reaction channels employed as energy monitors included NatNi(p,x)57Co and NatNi(p,x
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e9275a98c9cd6d75fc791d1565e0385
https://doi.org/10.1016/j.nimb.2019.01.038
https://doi.org/10.1016/j.nimb.2019.01.038
Autor:
Scott R. Daly, Kevin T. Bennett, Francois M. Nortier, Sharon E. Bone, Laura M. Lilley, C. Vermeulen, Veronika Mocko, Anastasia V. Blake, Benjamin W. Stein, Eva R. Birnbaum, Sara L. Thiemann, Christopher A. Martinez, Michael E. Fassbender, Maryline G. Ferrier, Jonathan W. Engle, Mark Brugh, Andrew C. Akin, Stosh A. Kozimor
Publikováno v:
ACS Central Science, Vol 5, Iss 3, Pp 494-505 (2019)
ACS Central Science
ACS Central Science
Radionuclides find widespread use in medical technologies for treating and diagnosing disease. Among successful and emerging radiotherapeutics, 119Sb has unique potential in targeted therapeutic applications for low-energy electron-emitting isotopes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c00e2ccdf37d4a30837ed06ab77216d
https://doaj.org/article/116aeabb09ca4141a5f9a9981eb10e94
https://doaj.org/article/116aeabb09ca4141a5f9a9981eb10e94
Autor:
Tara, Mastren, Andrew, Akin, Roy, Copping, Mark, Brugh, D Scott, Wilbur, Eva R, Birnbaum, Francois M, Nortier, Kevin D, John, Michael E, Fassbender
Publikováno v:
Nuclear medicine and biology.
Thorium-226 (half-life 30.6 m) is a radionuclide of interest for use in targeted alpha therapy applications. Due to its short half-life,A reverse radionuclide generator system was developed employing a DGA extraction chromatography column. AThorium-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::13f0dbd1aca13ec06e2ada3e48f87d6b
https://pubmed.ncbi.nlm.nih.gov/33068963
https://pubmed.ncbi.nlm.nih.gov/33068963
Autor:
Tara Mastren, Donald K. Hamlin, Chris Orvig, Michael E. Fassbender, Ming-Kuan Chyan, Lily Li, Roger Wong, Maryline G. Ferrier, Yawen Li, D. Scott Wilbur, Sarah Spreckelmeyer
Publikováno v:
Journal of labelled compoundsradiopharmaceuticalsREFERENCES. 63(12)
One of the main challenges in targeted alpha therapy is assuring delivery of the α-particle dose to the targeted cells. Thus, it is critical to identify ligands for α-emitting radiometals that will form complexes that are very stable, both in vitro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::284de6e46b2bdaea6b449fef71804da2
https://pubmed.ncbi.nlm.nih.gov/32812275
https://pubmed.ncbi.nlm.nih.gov/32812275
Autor:
Mitchell T, Friend, T Gannon, Parker, Tara, Mastren, Veronika, Mocko, Mark, Brugh, Eva R, Birnbaum, Michael E, Fassbender
Publikováno v:
Journal of chromatography. A. 1624
The alpha-emitter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::17e4e5116dc2990dfc937e313af09aa4
https://pubmed.ncbi.nlm.nih.gov/32540068
https://pubmed.ncbi.nlm.nih.gov/32540068